New Zealand approves risky weight-loss drug Wegovy despite alarming health risks abroad
New Zealand approves controversial weight loss drug Wegovy despite severe side effects like pancreatitis, kidney disease, and blindness. Officials are ignoring global warnings and prioritizing corporate interests over public safety. Fast-tracked drug approvals may strip safeguards under the Gene Technology Bill. Studies show Wegovy doubles pancreatitis risk and increases vision loss cases. Experts call for … Leer más